Literature DB >> 10724898

Bias in meta-analysis and funnel plot asymmetry.

M Biljana1, M Jelena, J Branislav, R Milorad.   

Abstract

International experiences reveal the important role played by scientific research and systematic study a problems, in effectively tackling change in the health sector. Meta-analysis was introduced to address the problem of synthesizing the large quantity of information on a particular subject. It is viewed, only as a step in the process of developing better tools to quantify information across studies. The selection of trials for inclusion in a meta-analysis may be biased if selection is restricted to published trials, to trials published in English language journals, to trials published in prestigious journals or to trials cited by other authors. Funnel plot is graphical display of sample size plotted against effect size for the studies included in a meta-analysis, which can be used to investigate bias. When all the studies have been located, the distribution of points should resemble a funnel. If there are gaps in the funnel shape it indicates that some studies may have not been published or located. In evaluating bias, we use meta-analysis studies about radiotherapy alone versus combined radiotherapy and chemotherapy in stages IIIa and IIIb non-small cell lung cancer. A simple analysis of funnel plots provides useful test for the likely presence of bias in meta-analyses, but as the capacity to detect bias will be limited when meta-analyses are based on a limited number of small trials the results from such analyses should be treated with considerable caution.

Entities:  

Mesh:

Year:  1999        PMID: 10724898

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  27 in total

1.  A randomized trial of hemodiafiltration and change in cardiovascular parameters.

Authors:  Irina M Mostovaya; Michiel L Bots; Marinus A van den Dorpel; Muriel P C Grooteman; Otto Kamp; Renée Levesque; Piet M Ter Wee; Menso J Nubé; Peter J Blankestijn
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 8.237

Review 2.  The efficacy of Yunnan Baiyao on haemostasis and antiulcer: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Bo Yang; Zhe-Qi Xu; Hao Zhang; Feng-Ying Xu; Xue-Yin Shi; Zui Zou; Chang-Quan Ling; Ling Tang
Journal:  Int J Clin Exp Med       Date:  2014-03-15

Review 3.  Rotary Instrument or Piezoelectric for the Removal of Third Molars: a Meta-Analysis.

Authors:  Rafael Alvim Magesty; Endi Lanza Galvão; Carolina de Castro Martins; Cássio Roberto Rocha Dos Santos; Saulo Gabriel Moreira Falci
Journal:  J Maxillofac Oral Surg       Date:  2016-07-09

Review 4.  Normocaloric versus hypocaloric feeding on the outcomes of ICU patients: a systematic review and meta-analysis.

Authors:  Paul E Marik; Michael H Hooper
Journal:  Intensive Care Med       Date:  2015-11-10       Impact factor: 17.440

Review 5.  Meta-analyses of antihypertensive therapy: Are some of them misleading?

Authors:  E Grossman; U Goldbourt
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

6.  Capecitabine plus oxaliplatin (XELOX) compared with 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOXs) in advanced gastric cancer: meta-analysis of randomized controlled trials.

Authors:  Hong-Bin Xu; Fang Huang; Rui Su; Fu-Ming Shen; Qian-Zhou Lv
Journal:  Eur J Clin Pharmacol       Date:  2015-03-21       Impact factor: 2.953

Review 7.  Prognostic factors for return to work of employees with common mental disorders: a meta-analysis of cohort studies.

Authors:  Yeshambel T Nigatu; Yan Liu; Mandi Uppal; Shelby McKinney; Katharine Gillis; Sanjay Rao; JianLi Wang
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-06-02       Impact factor: 4.328

Review 8.  Does celecoxib improve the efficacy of chemotherapy for advanced non-small cell lung cancer?

Authors:  Leng-Chen Hou; Fang Huang; Hong-Bin Xu
Journal:  Br J Clin Pharmacol       Date:  2015-11-02       Impact factor: 4.335

9.  Prognostic significance of STAT3/phosphorylated-STAT3 in tumor: a meta-analysis of literatures.

Authors:  Hongyu Kong; Qiongwen Zhang; Yunhui Zeng; Hong Wang; Mengqian Wu; Tianying Zheng; Yanzhang Zeng; Huashan Shi
Journal:  Int J Clin Exp Med       Date:  2015-06-15

10.  A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma.

Authors:  Lei Cao; Jia Lin; Bing He; Hongge Wang; Juan Rao; Yingwen Liu; Xuemei Zhang
Journal:  Tumour Biol       Date:  2013-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.